サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バイオマーカー発見アウトソーシングサービス市場：タイプ別、治療領域別、発見フェーズ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
市場調査レポート
商品コード
1388778

バイオマーカー発見アウトソーシングサービス市場：タイプ別、治療領域別、発見フェーズ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年

Biomarker Discovery Outsourcing Services Market, By Type, By Therapeutic Area, By Discovery Phase, By End Use, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 311 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
バイオマーカー発見アウトソーシングサービス市場：タイプ別、治療領域別、発見フェーズ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
出版日: 2023年11月01日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

バイオマーカー発見アウトソーシングサービス市場規模は2022年に112億1,000万米ドルと評価され、2023年から2030年までのCAGRは23.5%で拡大

バイオマーカー発見アウトソーシングサービス市場は、より広範な製薬・バイオテクノロジー分野の中で成長中の分野です。バイオマーカーは、分子または生物学的プロセスを定量化できる指標であり、疾病診断、個別化医療、医薬品開発など幅広い分野で応用されています。バイオマーカー発見アウトソーシングサービスは、学術研究機関、製薬会社、その他の組織がバイオマーカーを検証、利用、同定できるよう、専門的な知識とリソースを提供します。

バイオマーカー発見アウトソーシングサービス市場-市場力学

慢性疾患の有病率の上昇が市場成長を後押し

がん、心血管疾患、神経変性疾患、糖尿病などの慢性疾患の増加が市場拡大の主な要因となっています。さらに、コンパニオン診断薬の成長、がん検出のためのリキッドバイオプシーへの注目、データ解析のための機械学習と人工知能の利用は、市場の需要を促進する新たな動向です。さらに、個別化医療が普及し、標的治療や診断ツールの需要が増加するにつれて、バイオマーカー発見アウトソーシングサービス市場の需要は引き続き拡大すると予想されます。さらに、バイオマーカー発見はヘルスケアおよびライフサイエンス研究の重要な要素です。標的療法の開発、疾病メカニズムの解明、疾病の早期発見に役立ちます。このため、バイオマーカー研究を迅速化するアウトソーシングサービスの需要も高まっています。

バイオマーカー発見アウトソーシングサービス市場-セグメンテーション分析：

世界のバイオマーカー発見アウトソーシングサービス市場は、タイプ、治療領域、発見フェーズ、最終用途、地域に基づいてセグメント化されます。

タイプ別では、サロゲートエンドポイント、予測バイオマーカー、安全性バイオマーカー、予後バイオマーカー、その他の4つに分類されます。サロゲートエンドポイント分野が最も高い成長率を示しています。疾患の進行や患者の生存といった重要な目的を達成するために、臨床試験には何年もかかり、多大なリソースを必要とします。サロゲートバイオマーカーは、治療効果を早期に示すことができるため、臨床試験をより効率的かつ短期間で実施することが可能であり、このような利点が同分野の成長を促進すると予測されています。

同市場は、最終用途に基づき、バイオテクノロジー企業、製薬企業、その他の2つのカテゴリーに分類されます。バイオテクノロジー企業は、予測期間中もその優位性を維持するとみられます。アウトソーシングにより、バイオテクノロジー企業はCRO（医薬品開発業務受託機関）などの専門サービスプロバイダーの専門知識を活用することができます。バイオマーカー発見のアウトソーシングは、社内でチームや設備、インフラを維持するよりも費用対効果が高い可能性があります。バイオテクノロジー企業は、治療研究や医薬品開発などのコアコンピタンスに集中することで、より効果的にリソースを配分することができます。

バイオマーカー発見アウトソーシングサービス市場-地理的洞察

地域別分析では、バイオマーカー発見アウトソーシングサービス市場は北米、アジア太平洋地域、欧州、その他世界のその他の地域に区分されます。北米は、革新的な技術、強固なバイオテクノロジー産業、規制に関する専門知識、先進的なヘルスケアインフラへのアクセスにより、市場を独占する可能性が高いです。この地域では、米国食品医薬品局（FDA）やカナダ食品検査庁（CFIA）などの規制機関が、先端医薬品や診断におけるバイオマーカーの規制インフラとして有名です。このような規制の明確さが、検証作業やバイオマーカー研究を支えています。さらに、アジア太平洋地域は予測期間中に最大の成長を遂げると予測されています。この地域では、中国やインドなどの様々な経済圏がバイオテクノロジーと医薬品の新興市場とみなされています。これらの国々にとって、バイオマーカー発見プロジェクトをアウトソーシングする費用対効果は、世界の製薬ビジネスにとって魅力的です。

バイオマーカー発見アウトソーシングサービス市場-競合情勢：

この分野の企業は通常、バイオテクノロジー製薬企業の多様なニーズに応えるため、サンプル収集からデータ解析まで幅広いサービスを提供しています。さまざまな専門バイオテクノロジー企業やCRO（医薬品開発業務受託機関）がバイオマーカー発見サービスを提供しています。これらの企業は、顧客に代わってバイオマーカー関連の研究開発を実施するためのインフラと専門知識を有しています。同市場は、より包括的なバイオマーカー発見を可能にするプロテオミクスやゲノミクスの技術進歩の影響を受けています。この分野で事業を展開する市場プレーヤーは、市場での事業基盤を維持するため、提携、パートナーシップ、新製品の発売など、いくつかの戦略的イニシアチブを採用しています。

目次

第1章 バイオマーカー発見アウトソーシングサービス市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオマーカー発見アウトソーシングサービスの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 バイオマーカー発見アウトソーシングサービス業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 バイオマーカー発見アウトソーシングサービス市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 バイオマーカー発見アウトソーシングサービス市場情勢

  • バイオマーカー発見アウトソーシングサービス市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオマーカー発見アウトソーシングサービス市場：タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • サロゲートエンドポイント
    • 予測バイオマーカー
    • 安全性バイオマーカー
    • 予後バイオマーカー
    • その他

第8章 バイオマーカー発見アウトソーシングサービス市場：治療領域別

  • 概要
    • 治療領域別のセグメントシェア分析
    • 自己免疫疾患
    • 腫瘍
    • 心臓病
    • 神経内科
    • その他

第9章 バイオマーカー発見アウトソーシングサービス市場：発見フェーズ別

  • 概要
    • 発見フェーズ別のセグメントシェア分析
    • バイオマーカーの選択
    • バイオマーカーの同定
    • バイオマーカーの検証
    • バイオマーカーパネルの開発
    • バイオマーカープロファイリング

第10章 バイオマーカー発見アウトソーシングサービス市場：最終用途別

  • 概要
    • 最終用途別のセグメントシェア分析
    • バイオテクノロジー企業
    • 製薬企業
    • その他

第11章 バイオマーカー発見アウトソーシングサービス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：バイオマーカー発見アウトソーシングサービス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • GHO Capital
    • ICON plc
    • Agilent
    • Proteome Sciences
    • Charles River Laboratories.
    • Eurofins Scientific
    • Celerion
    • Evotec
    • Parexel International（MA）Corporation

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biomarker Discovery Outsourcing Services Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Type2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Therapeutic AreaSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Discovery Phase Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Discovery Phase
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: End Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by End Use 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
目次
Product Code: ANV1840

REPORT HIGHLIGHT

Biomarker discovery outsourcing services market size was valued at USD 11,210 Million in 2022, expanding at a CAGR of 23.5% from 2023 to 2030.

The biomarker discovery outsourcing services market is a growing sector within the broader pharmaceutical and biotechnology sector. Biomarkers are quantifiable indicators of molecular or biological processes with a wide range of applications in areas including disease diagnosis, personalized medicine, and drug development. Biomarker discovery outsourcing services provide specialized expertise and resources to help academic research institutions, pharmaceutical companies, and other organizations validate, utilize, and identify biomarkers for several purposes.

Biomarker Discovery Outsourcing Services Market- Market Dynamics

The rising prevalence of chronic diseases is propelling market growth

The increase in the prevalence of chronic diseases including cancer, cardiovascular diseases, neurodegenerative conditions, and diabetes are major contributing factors to the market expansion. Additionally, the growth of companion diagnostics, a focus on liquid biopsy for cancer detection, and the use of machine learning and artificial intelligence for data analysis are emerging trends fueling the demand of the market. Moreover, as personalized medicine becomes more prevalent and as the demand for targeted therapies and diagnostic tools increases, thus, the demand for biomarker discovery outsourcing services market is expected to continue growing. Furthermore, biomarker discovery is a crucial component of healthcare and life sciences research. It aids in developing targeted therapies, understanding disease mechanisms, and the early detection of diseases. This also led to a rising demand for outsourcing services to expedite biomarker research.

Biomarker Discovery Outsourcing Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global biomarker discovery outsourcing services market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2023-2030)
  • The biomarker discovery outsourcing services industry is projected to grow at a significant rate due to the growing demand for personalized medicine
  • Based on type segmentation, surrogate endpoints was predicted to show maximum market share in the year 2022
  • Based on end use segmentation, biotechnology companies was the leading type in 2022
  • Based on Region, North America was the leading revenue generator in 2022.

Biomarker Discovery Outsourcing Services Market- Segmentation Analysis:

The global biomarker discovery outsourcing services market is segmented on the basis of type, therapeutic area, discovery phase, end use, and region.

The market is divided into four categories based on type: surrogate endpoints, predictive biomarkers, safety biomarkers, prognostic biomarkers, and others. The surrogate endpoints segment is accounted to witness the highest growth rate. To accomplish crucial objectives such as disease progression or patient survival, clinical trials can take years and need substantial resources. Surrogate biomarkers enables for more efficient and shorter clinical trials because they can offer early indications of treatment efficacy, such advantages are projected to drive the segment's growth

The market is divided into two categories based on end use: biotechnology companies, pharmaceutical companies, and others. The biotechnology companies segment is likely to maintain its dominance over the forecast period. Outsourcing enables biotechnology companies to tap into the expertise of specialized service providers, such as Contract Research Organizations (CROs). Outsourcing biomarker discovery might be cost-effective over maintaining in-house teams, equipment, and infrastructure. Biotechnology companies can allocate resources more effectively by focusing on their core competencies, like therapeutic research or drug development.

Biomarker Discovery Outsourcing Services Market- Geographical Insights

By regional analysis, the biomarker discovery outsourcing services market can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. North America is likely to dominate the market due to its access to innovating technologies, robust biotech industry, regulatory expertise, and advanced healthcare infrastructure. In the region, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA), have renowned regulatory infrastructure for biomarkers in advanced drugs and diagnostics. This regulatory clarity supports validation efforts and biomarker research. Furthermore, Asia Pacific is anticipated to witness maximum growth during the forecast period. In the region, various economies such as China and India are considered emerging markets for biotechnology and pharmaceuticals. To these countries, the cost-effectiveness of outsourcing biomarker discovery projects can be attractive to worldwide pharmaceutical business.

Biomarker Discovery Outsourcing Services Market- Competitive Landscape:

Businesses in this space typically provide a vast range of services, from sample collection to data analysis, to meet the diverse needs of biotechnology pharmaceutical clients. Various specialized biotechnology companies and contract research organizations (CROs) offer biomarker discovery services. These companies have the infrastructure and expertise to carry out biomarker-related research and development on behalf of their clients. The market is influenced by the advancement of technology in proteomics and genomics which allow more comprehensive biomarker discovery. Market players operating in this sector are adopting several strategic initiatives, such as collaborations, partnerships, and new product launches, to maintain their business foothold in the market.

Recent Developments:

In January 2022, Inotiv, Inc. and Synexa Life Sciences announced that they intend to form a collaboration that will accelerate Inotiv's development of biomarkers important to the understanding of efficacy and safety of novel biotherapeutics, improve the business preclinical discovery and safety assessment services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • GHO Capital
  • ICON plc
  • Agilent
  • Proteome Sciences
  • Charles River Laboratories.
  • Eurofins Scientific
  • Celerion
  • Evotec
  • Parexel International (MA) Corporation

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE

  • Surrogate endpoints
  • Predictive biomarkers
  • Safety biomarkers
  • Prognostic biomarkers
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA

  • Autoimmune Diseases
  • Oncology
  • Cardiology
  • Neurology
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY DISCOVERY PHASE

  • Biomarker Selection
  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Panel Development
  • Biomarker Profiling

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Biomarker Discovery Outsourcing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biomarker Discovery Outsourcing Services Market Snippet by Type
    • 2.1.2. Biomarker Discovery Outsourcing Services Market Snippet by Therapeutic Area
    • 2.1.3. Biomarker Discovery Outsourcing Services Market Snippet by Discovery Phase
    • 2.1.4. Biomarker Discovery Outsourcing Services Market Snippet by End Use
    • 2.1.5. Biomarker Discovery Outsourcing Services Market Snippet by Country
    • 2.1.6. Biomarker Discovery Outsourcing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Biomarker Discovery Outsourcing Services Key Market Trends

  • 3.1. Biomarker Discovery Outsourcing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biomarker Discovery Outsourcing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biomarker Discovery Outsourcing Services Market Opportunities
  • 3.4. Biomarker Discovery Outsourcing Services Market Future Trends

4. Biomarker Discovery Outsourcing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biomarker Discovery Outsourcing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biomarker Discovery Outsourcing Services Market Landscape

  • 6.1. Biomarker Discovery Outsourcing Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biomarker Discovery Outsourcing Services Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Surrogate endpoints
    • 7.1.3. Predictive biomarkers
    • 7.1.4. Safety biomarkers
    • 7.1.5. Prognostic biomarkers
    • 7.1.6. Others

8. Biomarker Discovery Outsourcing Services Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022&2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Oncology
    • 8.1.4. Cardiology
    • 8.1.5. Neurology
    • 8.1.6. Others

9. Biomarker Discovery Outsourcing Services Market - By Discovery Phase

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Discovery Phase, 2022&2030 (%)
    • 9.1.2. Biomarker Selection
    • 9.1.3. Biomarker Identification
    • 9.1.4. Biomarker Validation
    • 9.1.5. Biomarker Panel Development
    • 9.1.6. Biomarker Profiling

10. Biomarker Discovery Outsourcing Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2022&2030 (%)
    • 10.1.2. Biotechnology Companies
    • 10.1.3. Pharmaceutical Companies
    • 10.1.4. Others

11. Biomarker Discovery Outsourcing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biomarker Discovery Outsourcing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Biomarker Discovery Outsourcing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Laboratory Corporation of America Holdings
    • 12.2.3. GHO Capital
    • 12.2.4. ICON plc
    • 12.2.5. Agilent
    • 12.2.6. Proteome Sciences
    • 12.2.7. Charles River Laboratories.
    • 12.2.8. Eurofins Scientific
    • 12.2.9. Celerion
    • 12.2.10. Evotec
    • 12.2.11. Parexel International (MA) Corporation

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us